Monoamine oxidase inhibitors (MAOI) have been acknowledged to lengthen and boost the consequences of dimethyltryptamine (copyright) and 1 review assumed which the effect on psilocybin might be similar since it is often a structural analogue of copyright.[145] Nonetheless, only a little percentage of psilocin appears to get metabolized by MAO.[sixteen] https://psychedelicslegality69246.blogdun.com/31231702/fascination-about-copyright-therapy